Buckhead Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $2.78M | Sell |
|
|||||
|
2024
Q4 | $3.53M | Sell |
|
|||||
|
2024
Q3 | $4.16M | Sell |
|
|||||
|
2024
Q2 | $4.41M | Buy |
|
|||||
|
2024
Q1 | $5.57M | Buy |
|
|||||
|
2023
Q4 | $4.76M | Buy |
|
|||||
|
2023
Q3 | $3.77M | Buy |
|
|||||
|
2023
Q2 | $3.66M | Sell |
|
|||||
|
2023
Q1 | $4.05M | Buy |
|
|||||
|
2022
Q4 | $4.01M | Buy |
|
|||||
|
2022
Q3 | $2.69M | Buy |
|
|||||
|
2022
Q2 | $1.55M | Buy |
|